Functional and molecular characterization of Aspergillus fumigatus phosphoglucomutase (Pgm): a potential target for

Conrad C Achilonu1, Theodore J Kottom1, Andrew H Limper1

  • 1Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, Mayo Clinic, Rochester, MN, USA.

Insights

Aspergillus fumigatus phosphoglucomutase (AfPGM) is crucial for fungal growth and cell wall integrity. Inhibiting AfPGM selectively offers a promising strategy for developing new antifungal therapies.

Area of Science:

  • Biochemistry
  • Mycology
  • Molecular Biology

Background:

  • Aspergillus fumigatus phosphoglucomutase (AfPGM) is a key enzyme in fungal carbohydrate metabolism.
  • AfPGM generates essential precursors for cell wall polysaccharide synthesis.
  • Its precise role in fungal viability and cell wall integrity requires further elucidation.

Purpose of the Study:

  • To characterize the functional role of AfPGM in fungal growth.
  • To investigate AfPGM's contribution to cell wall phenotypes and biofilm formation.
  • To evaluate AfPGM as a potential antifungal target.

Main Methods:

  • Utilized a conditional A. fumigatus PalcA::pgm mutant to assess growth and biofilm formation.
  • Performed functional complementation by expressing Afpgm in a Saccharomyces cerevisiae pgm2Δ strain.
  • Examined enzymatic inhibition using the isothiazolone compound ISFP10.

Main Results:

  • Reduced AfPGM activity led to impaired growth, altered cell wall phenotypes, and decreased biofilm biomass.
  • Heterologous expression of Afpgm restored wild-type phenotypes in yeast, confirming functional conservation.
  • ISFP10 effectively inhibited AfPGM activity and disrupted fungal phenotypes.

Conclusions:

  • AfPGM plays a significant role in fungal carbohydrate metabolism and cell wall biology.
  • Selective inhibition of AfPGM by ISFP10 highlights its potential as an antifungal target.
  • AfPGM represents a promising avenue for novel antifungal drug development.